FDA Approves New Heart Failure Drug

Entresto tablets have been approved for the treatment of heart failure.

The U.S. Food and Drug Administration has approved Entresto tablets for the treatment of heart failure. The drug has been shown to reduce the rate of cardiovascular death and hospitalization related to heart failure, according to the agency.

"Heart failure is a leading cause of death and disability in adults," said Dr. Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products in FDA's Center for Drug Evaluation and Research. "Treatment can help people with heart failure live longer and enjoy more active lives.

FDA reported the most common side effects in clinical trial participants being treated with Entresto were low blood pressure, high blood potassium levels, and poor kidney function. Entresto is manufactured by Novartis, based in East Hanover, N.J.

Download Center

HTML - No Current Item Deck

OH&S Digital Edition

  • OHS Magazine Digital Edition - April 2021

    April 2021

    Featuring:

    • TRAINING: ELECTRICAL SAFETY
      Tips on Creating an Effective Electrical PPE Programs
    • PPE: VISION PROTECTION
      Considerations for Choosing Eye Protection
    • WELDING
      A New Paradigm for Reducing Contaminated Welds
    • CONFINED SPACES
      Limiting the Risk of Exposure with the Correct PPE
    View This Issue